evipedia.ai
← Back

Fermented Cod Liver Oil for Health & Longevity

Evidence Review created on 09/09/2026 using AI4L / Opus 5

Also known as: FCLO, Fermented Fish Liver Oil, Blue Ice Fermented Cod Liver Oil, Green Pasture Fermented Cod Liver Oil

Motivation

Fermented cod liver oil is made by letting cod livers break down in brine for months, rather than heating or refining them. Sellers present it as a whole food rather than a supplement: a spoonful is said to carry vitamins A and D, the long-chain fats of oily fish, and other compounds that gentle processing preserves.

Plain cod liver oil has been taken in northern Europe for two centuries, first for aching joints and later as the standard treatment for the childhood bone disease caused by too little sunlight. The fermented version revives an older barrel method and comes from one small producer. A privately commissioned laboratory report later questioned its freshness, its vitamin content and even the fish it came from.

This review examines what is known about the fermented product: how the fermentation step changes the oil, what the human evidence on cod liver oil supports, where the fermented version’s composition remains unverified, and how the reported benefits and harms compare for adults who take it with long-term health in mind.

Benefits - Risks - Protocol - Conclusion

Commentary and long-form discussion that frame the fermented cod liver oil dispute and the marine omega-3 category it belongs to.

  • Important Update on Cod Liver Oil - Chris Kresser

    A practitioner who recommended the product for years works through the disputed laboratory report claim by claim, including why free fatty acid values are a poor rancidity test.

  • Weighing in on the Fermented Cod Liver Oil (FCLO) Controversy - Chris Masterjohn

    The most technically detailed response to that report, opening with a full disclosure of the author’s financial ties and arguing that vitamin D activity in liver oils is poorly captured by routine assays.

  • Questions and Answers About Fermented Cod Liver Oil (FCLO) - Sally Fallon Morell

    The endorsing organisation’s own defence, valuable mainly because it discloses the payments it received from the manufacturer and describes the aldehyde testing it commissioned.

  • #83 – Bill Harris, Ph.D.: Omega-3 fatty acids - Peter Attia

    Qualifies through the shared target: the membrane incorporation of eicosapentaenoic acid and docosahexaenoic acid that any cod liver oil relies on. Covers dosing, blood testing and supplement quality.

  • How the Omega-3 Index Helps Track Longevity Risk - Rhonda Patrick

    Qualifies via the shared mechanism — red-cell incorporation of eicosapentaenoic and docosahexaenoic acid — and explains the omega-3 index (their share of red-cell fats) as a check on any label claim.

Content from Andrew Huberman, Life Extension Magazine and Lifespan.io is not listed because no article, episode or lecture from those platforms discusses cod liver oil, fermented or otherwise, in substantial depth. Life Extension’s only cod liver oil item is a 2008 news brief summarising the rheumatoid arthritis trial already cited below, Lifespan.io’s only mention is one sentence inside a news summary of a UK Biobank organ-ageing analysis, and Huberman Lab’s coverage exists only as short answer-engine clips.

Grokipedia

  • Cod liver oil

    Grokipedia has no dedicated fermented cod liver oil article; this is its primary page for the oil, and it describes the traditional barrel fermentation that the modern product revives.

Examine

  • Cod Liver Oil

    Examine’s monograph states plainly that despite a long history of use there is limited clinical evidence on cod liver oil, a useful counterweight to marketing claims for the fermented version.

ConsumerLab

Systematic Reviews

Pooled evidence on the constituents and principal risks of fermented cod liver oil, since no systematic review or meta-analysis addresses the fermented product itself.

Mechanism of Action

Fermented cod liver oil delivers four active fractions, and the fermentation step is claimed to change how they survive processing.

The marine fats eicosapentaenoic acid (EPA, a long-chain omega-3 fat) and docosahexaenoic acid (DHA, its longer partner) are built into cell membranes in place of arachidonic acid (an omega-6 fat), shifting eicosanoid output (the short-lived signalling molecules that start and stop inflammation) toward less inflammatory prostaglandins and toward resolvins, which actively switch inflammation off.

Ready-made vitamin A (retinol) is converted to retinoic acid, which binds nuclear retinoic acid receptors and retinoid X receptors (proteins that switch genes on and off) to control gene activity in skin, gut lining, immune and visual tissue. Vitamin D3 is converted in the liver to 25-hydroxyvitamin D and in the kidney to calcitriol, the active vitamin D hormone, acting through the vitamin D receptor. The two vitamins compete, because the retinoid X receptor is a shared docking partner and heavy retinol intake can blunt vitamin D signalling.

Fermentation is where accounts diverge. The manufacturer and one analytical group hold that anaerobic breakdown of the liver liberates collagen-derived peptides, biogenic amines (small nitrogen compounds formed as protein breaks down) and phenolic compounds that mop up aldehydes and shield the fragile omega-3 fats. Critics hold that the same breakdown is autolysis (the tissue digesting itself), which liberates free fatty acids and oxidation products while degrading vitamins A, D and K. Both readings rest on laboratory chemistry, not on human outcome data.

Historical Context & Evolution

Cod liver oil entered European medicine in the eighteenth century as a folk remedy for rheumatism, then became the standard treatment for rickets (the childhood bone disease of vitamin D deficiency), and was given in tuberculosis wards. The pre-industrial method left livers in barrels until they broke down and released their oil; Peter Möller’s steam process of the 1850s replaced it with a cleaner-tasting product.

Interest in the older method revived through dentist Weston A. Price, who in the 1930s paired cod liver oil with a high-vitamin butter oil and reported arrest of dental decay, attributing this to an unidentified “Activator X” later identified as menaquinone-4, a form of vitamin K2. From about 2003 a single producer, Green Pasture, revived barrel fermentation commercially, and the Weston A. Price Foundation endorsed it — while receiving $20,610 from that manufacturer in 2014 alone.

In 2015 a foundation board member, Kaayla Daniel, commissioned independent testing and published a paid report concluding that one of three batches was rancid by free fatty acid measurement, that vitamins A, D and K sat below the levels claimed, that trans fats indicated added vegetable oil, and that DNA and an EPA-above-DHA profile pointed to Alaska pollock rather than cod. Those findings were contested rather than withdrawn: the manufacturer and independent chemists argued free fatty acids do not measure oxidation, and commissioned aldehyde testing found none. What changed since is the product itself — now certified wild Alaska cod, with no vitamin A or D figure declared.

Expected Benefits

High 🟩 🟩 🟩

No benefit reaches High: no randomised trial has tested the fermented product on any human clinical endpoint, and the conventional cod liver oil trials that do report clinical endpoints each measure a different outcome, so no outcome is replicated across more than one trial.

Medium 🟩 🟩

Reduced Anti-Inflammatory Drug Requirement in Rheumatoid Arthritis

Cod liver oil allows people with rheumatoid arthritis to cut their non-steroidal anti-inflammatory drug (NSAID, the ibuprofen-type painkiller class) dose without symptoms worsening, an effect attributed to omega-3 displacement of inflammatory signalling. The evidence is one dual-centre, double-blind randomised controlled trial (RCT, a study in which participants are randomly assigned to treatment or placebo) of 97 patients, supported by a meta-analysis of 42 marine oil trials. Neither used a fermented oil, and disease activity did not improve — only drug requirement fell.

Magnitude: 39% of the cod liver oil group versus 10% of the placebo group cut daily NSAID use by more than 30% over nine months, an absolute difference of 29 percentage points (Galarraga et al., 2008; Senftleber et al., 2017).

Low 🟩

Lower Basal and Exercise-Induced C-Reactive Protein

Regular cod liver oil users show lower resting and post-exertion C-reactive protein (CRP, a blood marker of body-wide inflammation), consistent with the resolvin pathway described above. Evidence is one uncontrolled prospective cohort of recreational cyclists in which cod liver oil, not omega-3 supplements generally, drove the effect.

Magnitude: cod liver oil users had a 34% lower CRP response to a 91 km race unadjusted (95% confidence interval, CI, the range within which the true value probably lies: 19–49), and 24% lower after adjustment (95% CI 11–38) (Hansen et al., 2021).

Ready-Made Vitamin A Delivery ⚠️ Conflicted

Liver oils supply retinol directly, bypassing the plant-pigment conversion step. Conventional cod liver oil provides roughly 1,350 µg retinol activity equivalents per teaspoon. Independent testing found the fermented product below claimed levels, and the manufacturer declares no figure. Net reading: the fraction is present, its dose unknown.

Magnitude: direction only — the oil raises ready-made vitamin A intake, and in conventional cod liver oil one teaspoon supplies about 150% of the adult reference intake; the literature reports no retinol figure for the fermented product (Penniston & Tanumihardjo, 2006).

Vitamin D Status Support ⚠️ Conflicted

Conventional cod liver oil raises serum 25-hydroxyvitamin D and is a recognised winter source at Nordic latitudes. Independent assay found little D2 or D3 in the fermented oil; the manufacturer’s animal bioassay suggested roughly 400 IU (international units) per teaspoon. Net reading: real but unverified.

Magnitude: direction and conditions — cod liver oil raises 25-hydroxyvitamin D where baseline status is low, and pooled trial data put the useful daily range at 400–1000 IU; no assay has established the fermented product’s dose (Jolliffe et al., 2021).

Prevention of Respiratory Infection ⚠️ Conflicted

Small paediatric studies and vitamin D pooling suggested cod liver oil should reduce infections. A 34,601-participant Norwegian randomised trial in working-age adults found no reduction in coronavirus infection, severe disease or self-reported respiratory infection. Net reading: at ordinary doses, cod liver oil does not prevent respiratory infection.

Magnitude: relative risk (the risk in the supplemented group divided by the risk in the placebo group) 1.00 (95% CI 0.82–1.22) for a positive coronavirus test and 1.04 (95% CI 0.97–1.11) for any acute respiratory infection over a median 164 days (Brunvoll et al., 2022).

Triglyceride and Cholesterol Change ⚠️ Conflicted

Marine oils lower triglycerides by cutting liver triglyceride output, and pooled omega-3 trials confirm it. Cod liver oil trials disagree: one crossover study lowered triglycerides but raised low-density lipoprotein cholesterol in men, a 14-month trial found nothing. Net reading: a class effect cod liver oil has not reliably reproduced.

Magnitude: serum triglycerides fell by 0.21 mmol/L and low-density lipoprotein cholesterol rose by 0.28 mmol/L in men after eight weeks of 25 mL daily, with no change in women, while a 14-month trial found no lipid effect (Hansen et al., 1993; Brox et al., 2001).

Slightly Lower Coronary Heart Disease Event Rate

Marine omega-3 fats modestly reduce coronary heart disease events and deaths, plausibly through the triglyceride and eicosanoid changes described above. Evidence is a Cochrane pooling of supplement trials, none using cod liver oil, and the same pooling found no effect on all-cause mortality or on cardiovascular events overall.

Magnitude: relative risk 0.91 (95% CI 0.85–0.97) for coronary heart disease events and 0.90 (95% CI 0.81–1.00) for coronary heart disease death, across 86 trials and 162,796 participants (Abdelhamid et al., 2020).

Lower Type 1 Diabetes Risk After Early-Life Exposure

Two Norwegian population studies link cod liver oil in infancy, and in pregnancy, to less childhood type 1 diabetes, plausibly through vitamin D and omega-3 immune modulation. This matters to adults planning a family rather than to their own longevity. The data are observational and involved no fermented product.

Magnitude: adjusted odds ratio (the odds of the outcome among users divided by the odds among non-users) 0.74 (95% CI 0.56–0.99) for use in the first year of life, across 545 cases and 1,668 controls (Stene & Joner, 2003).

Lower Multiple Sclerosis Risk After Adolescent Exposure

Cod liver oil taken between ages 13 and 18 tracks with less adult-onset multiple sclerosis (a disease in which the immune system strips the insulation from nerve fibres), plausibly through vitamin D immune modulation. Evidence is one Norwegian case-control study, so recall bias cannot be excluded.

Magnitude: odds ratio 0.67 (95% CI 0.52–0.86) for supplement use at ages 13–18, across 953 cases and 1,717 controls, with the strongest reduction at an estimated 600–800 IU of vitamin D daily (Cortese et al., 2015).

Child Neurodevelopment After Maternal Supplementation ⚠️ Conflicted

Cod liver oil through pregnancy and lactation raised children’s intelligence at four years, plausibly through docosahexaenoic acid supply to the developing brain, relevant to adults planning a family. Evidence is a randomised double-blind trial whose seven-year follow-up found no difference. Net reading: an early gain that did not persist.

Magnitude: mental processing composite 106.4 versus 102.3 on corn oil at four years across 84 children, with no difference among the 143 retested at seven (Helland et al., 2003; Helland et al., 2008).

Lower Prevalence of Depressive Symptoms

Daily cod liver oil users report fewer depressive symptoms than non-users, plausibly through the same membrane omega-3 route that mood trials of eicosapentaenoic acid have targeted. Evidence is one large cross-sectional Norwegian population survey, so reverse causation and healthy-user effects cannot be excluded.

Magnitude: high depressive-symptom prevalence was 2.5% among daily users versus 3.8% among the rest, an adjusted odds ratio of 0.71 (95% CI 0.52–0.97) across 21,835 adults, with prevalence falling as duration of use rose (Raeder et al., 2007).

Speculative 🟨

Greater Oxidative Stability Than Non-Fermented Cod Liver Oils

Collagen peptides, phenolics and amines released during fermentation gave higher antioxidant capacity and fewer aldehydes under heat stress than unfermented oils. Basis is laboratory chemistry, manufacturer co-authored (Percival et al., 2020).

Vitamin K2 Contribution to Bone and Arterial Calcium Handling

Weston Price’s “Activator X” is now identified as menaquinone-4, proposed to direct calcium into bone rather than arteries. Basis is historical observation and mechanism; independent testing found vitamin K below claimed levels.

Benefit-Modifying Factors

  • Baseline vitamin D status: the vitamin D fraction can only help someone starting low. Pooled trial data show respiratory benefit clustering at daily equivalents of 400–1000 IU, so anyone already above 30 ng/mL of 25-hydroxyvitamin D can expect little further gain.

  • Baseline omega-3 index: habitual oily-fish eaters sit near 8% red-cell EPA plus DHA and gain little; those below 4% have the most room to move. Measuring first converts a guess into a decision.

  • FADS1 and FADS2 variants: these genes encode the desaturase enzymes that build EPA and DHA from plant omega-3. Slow-converting variants are common and make ready-made marine EPA and DHA, such as cod liver oil supplies, disproportionately valuable.

  • BCO1 genotype: BCO1 encodes the enzyme that splits beta-carotene into retinol. Low-activity variants affect roughly 45% of people and make ready-made retinol from liver oil more useful than plant carotenoids for vitamin A status.

  • Fat malabsorption conditions: cholestasis (blocked bile flow), pancreatic insufficiency, coeliac disease, Crohn’s disease and bariatric surgery all blunt uptake of the fat-soluble fractions. A fat-containing meal partially compensates; severe cases need measured status rather than assumed intake.

  • Sex differences: women convert plant omega-3 to DHA more efficiently and reach higher red-cell DHA at equal intake, so the marginal value of supplemental DHA is generally smaller in women. Vitamin A fracture risk, conversely, is reported more consistently in women.

  • Age: skin vitamin D synthesis falls roughly fourfold between age 20 and 70, raising the value of a dietary source. In parallel, liver retinol stores accumulate with age, so the same dose carries more vitamin A risk at 65 than at 35.

Potential Risks & Side Effects

High 🟥 🟥 🟥

No risk reaches High: the only adverse-event data of clinical-endpoint class come from conventional cod liver oil trials, and in those the events recorded were low-grade and did not differ from placebo, so no harm is documented across more than one trial.

Medium 🟥 🟥

Hip Fracture from Cumulative Ready-Made Vitamin A

Retinol above roughly twice the reference intake is associated with bone loss and hip fracture, mechanistically through retinoic acid stimulation of bone-resorbing osteoclasts and antagonism of vitamin D signalling. The evidence is consistent prospective cohort data, not trials, and confounding by liver consumption cannot be excluded. For an adult intending decades of daily use this is the single most relevant hazard, because it is cumulative, silent, and invisible on a routine blood panel.

Magnitude: adjusted relative risk 1.29 (95% CI 1.07–1.57) for hip fracture at the highest versus lowest vitamin A intake, 1.40 (95% CI 1.03–1.91) for retinol specifically, and 1.87 (95% CI 1.31–2.65) at the highest blood retinol (Wu et al., 2014).

Reduced Platelet Aggregation

Cod liver oil shifts platelet membrane composition toward EPA, producing thromboxane A3 in place of the more strongly clumping thromboxane A2, and measurably damps platelet function. Two controlled human studies show the effect, which is a surrogate rather than a bleeding-event count; in the earlier of them bleeding time itself was not significantly prolonged, and large omega-3 trials have not shown excess major bleeding. It matters chiefly for adults already taking anticoagulant or antiplatelet drugs, or approaching a procedure.

Magnitude: direction and conditions — collagen-induced aggregation and thromboxane generation fall after six to eight weeks of 25–30 mL daily, the aggregation effect reaching significance in men only where sexes were compared, while bleeding time was not significantly prolonged; these trials report no bleeding-event figure (Brox et al., 1983; Hansen et al., 1993).

Low 🟥

Undeclared Nutrient Content and Disputed Species Provenance ⚠️ Conflicted

Independent testing reported vitamins A, D and K below claim, and DNA plus an EPA-above-DHA profile suggesting Alaska pollock; the manufacturer now certifies wild Alaska cod and declares no vitamin figures. Net reading: the fractions people buy the oil for are not quantified on the label.

Magnitude: direction only — label-content shortfalls are common across marine oil supplements, with fewer than one in ten products meeting all quality indices in one market survey; no study has quantified batch-to-batch variation in this product (Albert et al., 2015; manufacturer product page).

Rancidity and Aldehydic Oxidation Products ⚠️ Conflicted

One of three tested batches was rancid by free fatty acid values, and one laboratory found malondialdehyde (an oxidation by-product) tenfold higher than in comparison oils; peroxide, anisidine and total oxidation values were largely normal, and aldehyde analysis found no rancidity. Net reading: plausible but unproven.

Magnitude: direction and conditions — oxidation markers diverge by assay and by batch and rise with storage warmth; the literature reports no consolidated oxidation figure for this product (Percival et al., 2020, again with the manufacturer as a co-author).

Vitamin A Toxicity at High Cumulative Intakes

Chronic retinol excess causes high blood calcium, liver injury, bone pain, hair loss and raised pressure around the brain. Evidence is uncontrolled case-based human data, mostly from concentrated capsules rather than liver oils, though cod liver oil is a recognised historical source.

Magnitude: across 31 synthesised reports, high blood calcium appeared in 29%, digestive signs in 26%, and neurological and liver involvement in 23% each (Padmakar, 2026).

Gastrointestinal Intolerance

Fishy eructation (burping), nausea and loose stools are the common complaints with any marine oil, and the manufacturer’s own guidance tells users who develop digestive symptoms to stop. Controlled cod liver oil trials recorded only low-grade events that did not exceed placebo.

Magnitude: direction only — complaints are dose-related and appear early; the 34,601-participant trial reported only “low grade side effects” in both arms without a rate (Brunvoll et al., 2022).

Atrial Fibrillation with Marine Omega-3 Intake

Marine omega-3 supplements raise the risk of atrial fibrillation (an irregular, fast heart rhythm), probably by altering electrical conduction in heart-muscle membranes. Evidence is a meta-analysis of seven cardiovascular outcome trials of omega-3 concentrates, not cod liver oil, and the effect scales with dose.

Magnitude: hazard ratio (the event rate in the supplemented group divided by that in the placebo group) 1.25 (95% CI 1.07–1.46) across 81,210 participants, and 1.12 (95% CI 1.03–1.22) in trials testing 1 g or less of omega-3 daily, the range a cod liver oil serving supplies (Gencer et al., 2021).

Adult-Onset Asthma with Daily Cod Liver Oil Use

Daily cod liver oil intake tracked with more new-onset asthma in Norwegian adults, an effect the authors attributed to the high ready-made vitamin A content of the formula sold before 1999. Evidence is one prospective cohort, uncontrolled for diet and unreplicated.

Magnitude: adjusted odds ratio 1.62 (95% CI 1.32–1.98) for incident asthma among daily users, across 17,528 adults followed for 11 years (Mai et al., 2013).

Speculative 🟨

Biogenic Amine Load

Chemical profiling gave the fermented oil a signature of 2-phenylethylamine, tyramine and tryptamine absent from unfermented oils, though within recommended limits. No human outcome data exist; manufacturer co-authored (Grootveld et al., 2020).

Trans Fat Fraction from the Fermentation Step

The 2015 report read the oil’s trans fats as evidence of added vegetable oil; the manufacturer’s own guidance attributes them to the cod’s natural composition. Basis is compositional chemistry, with no human outcome data.

Dioxin and Polychlorinated Biphenyl Exposure

Liver concentrates fat-soluble pollutants more than muscle, and surveys detect polychlorinated biphenyls in marine oil supplements. Basis is chemical measurement; no human study links liver oil supplements to pollutant harm (Bourdon et al., 2010).

Harm from Oxidised Marine Oil in Pregnancy

Rats given heavily oxidised fish oil in pregnancy showed high newborn mortality and maternal insulin resistance. Basis is animal work; a human trial found no shift in oxidative stress markers (Albert et al., 2016).

Risk-Modifying Factors

  • Baseline serum retinol and liver stores: blood retinol is regulated and stays normal until liver stores are large, so a normal value does not exclude accumulation. Fasting retinyl esters, the stored form, above 10% signal overload.

  • BCO1 and retinol transport variants: low-activity BCO1 raises the share of vitamin A arriving as ready-made retinol rather than regulated carotenoid conversion, removing the body’s natural brake and concentrating the fracture risk.

  • Liver disease and heavy alcohol use: the liver stores retinol in stellate cells, and vitamin A is directly toxic to a damaged or alcohol-exposed liver. Cirrhosis, hepatitis and daily alcohol all lower the toxic threshold sharply.

  • Chronic kidney disease: impaired clearance of retinol-binding protein raises circulating retinol, so a dose that is safe with normal kidney function can accumulate. Reported high blood calcium from vitamin A clusters in kidney failure.

  • Severe hypertriglyceridaemia: very high triglycerides increase the fraction of vitamin A carried on lipoproteins rather than bound to its transport protein, and that unbound fraction is what damages membranes, raising toxicity risk at ordinary doses.

  • Sex differences: vitamin A fracture associations are reported most consistently in postmenopausal women, in whom oestrogen loss already accelerates bone turnover. The platelet-damping effect, conversely, reached significance in men only in the one trial comparing sexes.

  • Age: older adults combine decades of accumulated liver retinol, thinner bone and higher rates of anticoagulant use, so both the fracture and bleeding hazards rise with age even as the vitamin D benefit also rises.

  • Fermented-food intolerance: people with histamine intolerance, or with mast cell activation syndrome (an over-reactive immune-cell disorder), react to the amine fraction that distinguishes this oil from refined ones.

Key Interactions & Contraindications

  • Oral retinoids (prescription vitamin A-derived drugs for acne and psoriasis: isotretinoin, acitretin, bexarotene, tretinoin): absolute contraindication. Additive vitamin A activity causes vitamin A excess, raised pressure around the brain and liver injury. The oil is stopped for the duration of retinoid therapy.

  • Tetracycline antibiotics (doxycycline, minocycline, tetracycline): caution. Both raise pressure around the brain, and the combination is a recognised trigger for headache and visual blurring. The mitigating action is suspending the oil for the duration of the antibiotic course.

  • Vitamin K antagonist anticoagulants (warfarin, acenocoumarol): caution, with two opposing effects — the omega-3 fraction damps platelet function while the vitamin K2 fraction opposes the drug. Weekly international normalised ratio (INR, a clotting-time index) checks for a month after any change are standard.

  • Direct oral anticoagulants and antiplatelets (apixaban, rivaroxaban, clopidogrel, aspirin): caution for bleeding from additive platelet inhibition. Standard practice is stopping the oil seven days before elective surgery, dental extraction or colonoscopy with planned polypectomy.

  • Over-the-counter NSAIDs (ibuprofen, naproxen, high-dose aspirin): caution. Additive antiplatelet effect and gastric irritation; this same combination is the intended one in rheumatoid arthritis dose-sparing, so the mitigating action is watching for bruising rather than avoidance.

  • Fat-absorption blockers (orlistat, cholestyramine, colestipol, mineral oil): caution for loss of efficacy. These strip fat-soluble vitamins from the gut; separating doses by at least four hours limits the loss, and the delivered vitamin A and D dose remains lower.

  • Monoamine oxidase inhibitors (older antidepressant class that blocks amine breakdown: phenelzine, tranylcypromine, selegiline, linezolid): caution for hypertensive crisis. The fermented oil carries tyramine and 2-phenylethylamine, the amines implicated in that reaction. This hazard is specific to the fermented product, not to refined oils.

  • Additive supplements — vitamin A, retinyl palmitate, high-dose multivitamins, beef liver, other fish or krill oils: caution for cumulative vitamin A excess, since these stack on both active fractions. Mitigate by summing total ready-made vitamin A against the 3,000 µg daily limit.

  • Additive bleeding-risk supplements (high-dose vitamin E, garlic extract, Ginkgo biloba, nattokinase, curcumin): caution. Each independently damps platelet function; combined with a marine oil they can produce easy bruising and prolonged bleeding without any laboratory abnormality appearing first.

  • Vitamin D supplements and ultraviolet-B exposure: monitor rather than avoid. The oil adds an unquantified vitamin D dose to whatever is already taken, while its retinol fraction competes for the shared retinoid X receptor partner, so measured status beats arithmetic.

  • Populations who should avoid Fermented Cod Liver Oil:

    • Pregnancy and women planning conception, because ready-made retinol above 3,000 µg daily causes birth defects and the product declares no vitamin A figure
    • Established vitamin A excess, or fasting retinyl esters above 10% of total vitamin A
    • Cirrhosis of Child-Pugh Class B or C, and active hepatitis
    • Chronic kidney disease stage 4 or 5 (estimated glomerular filtration rate, the kidney’s filtering rate, below 30 mL/min/1.73 m²)
    • Current oral retinoid therapy
    • Documented fish or shellfish anaphylaxis
    • Osteoporosis with a prior fragility fracture, where added ready-made retinol works against treatment

Risk Mitigation Strategies

  • Total ready-made vitamin A capped below 3,000 µg daily: the oil’s contribution is summed with multivitamins, liver and fortified foods. This is the direct guard against hip fracture and vitamin A toxicity, both cumulative and silent.

  • Half a teaspoon rather than a teaspoon: the manufacturer’s own serving is 2 mL. Halving the traditional teaspoon roughly halves retinol exposure while retaining most of the omega-3 dose, cutting the fracture risk that dominates long-term use.

  • Measured rather than assumed vitamin D contribution: because the label declares none, 25-hydroxyvitamin D is checked at baseline and again at 12 weeks before any separate vitamin D supplement is added. This prevents unintended stacking and vitamin D excess.

  • Refrigeration after opening, with a 60-day limit: cold, dark, tightly closed storage slows aldehyde formation. A bottle smelling of varnish or paint rather than mild fish is discarded — the practical guard against rancid oil.

  • Taken with a fat-containing meal: absorption of all four fractions depends on bile flow and dietary fat. This raises delivered dose without raising the amount consumed, and reduces the fishy eructation that drives most discontinuation.

  • Seven-day hold before any procedure with bleeding risk: surgery, dental extraction, biopsy or polypectomy. Platelet effects from marine oils persist for days after the last dose and are not visible on a standard coagulation panel.

  • Medication list screened for retinoids and tetracyclines before starting: these two classes account for the reported cases of raised pressure around the brain from combined vitamin A exposure, and the interaction is avoidable by timing alone.

  • Quarter-serving introduction over two weeks where amines are a concern: people with histamine intolerance or on a monoamine oxidase inhibitor detect the tyramine fraction at low exposure, before a flushing or blood-pressure reaction occurs.

Therapeutic Protocol

  • Standard traditional-foods protocol: 2–5 mL (half to one teaspoon) daily of the liquid oil, taken year-round with food. This is the regimen popularised by the Weston A. Price Foundation, which discloses manufacturer sponsorship, and by Green Pasture itself.

  • Competing approach — refined or extra-virgin cod liver oil: the same 5 mL daily using a steam-extracted or cold-pressed oil with declared vitamin A and D figures. Chris Kresser moved to this after the testing dispute.

  • Competing approach — unbundling the fractions: separate marine omega-3 concentrate, measured vitamin D3, and vitamin K2 as menaquinone-7, with no ready-made vitamin A. This is the mainstream supplement-industry position and permits exact dosing.

  • Best time of day: with the largest fat-containing meal, most often dinner. No body-clock argument favours morning or evening; bile flow and gastric fat content determine absorption and whether eructation occurs.

  • Half-life of the active fractions: red-cell EPA and DHA turn over with a half-life of roughly four to eight weeks, circulating 25-hydroxyvitamin D two to three weeks, liver retinol months. Steady state arrives separately for each.

  • Single versus split dosing: a single daily dose is standard and adequate, because all four fractions are stored rather than cleared quickly. Splitting into two doses serves only to reduce eructation or nausea.

  • Genetic factors in dose choice: low-activity BCO1 favours ready-made retinol but removes the conversion brake, arguing for the smaller serving. Slow FADS1 and FADS2 variants argue for keeping the marine omega-3 dose intact.

  • Sex-based differences: women reach higher red-cell DHA at equal intake and so need less for the omega-3 target, while carrying the more consistently reported vitamin A fracture association. Both point to the lower end of the range.

  • Age-related adjustment: protocols for adults over 65 typically use 2 mL rather than 5 mL, since liver retinol stores accumulate and bone reserve is lower, while the vitamin D need is met more precisely by a measured supplement.

  • Baseline biomarkers that set the dose: an omega-3 index below 4% and 25-hydroxyvitamin D below 30 ng/mL argue for the full serving; values already in range argue for the half serving or for unbundling the fractions.

  • Pre-existing conditions that change the protocol: fat malabsorption calls for a fat-containing meal and measured status; osteoporosis, liver disease and chronic kidney disease favour an omega-3 concentrate carrying no ready-made vitamin A.

Discontinuation & Cycling

  • Intended duration: framed by its advocates as a lifelong daily food rather than a course of treatment. The evidence base offers no trial longer than nine months, so open-ended use rests on tradition rather than on data.

  • Withdrawal effects: none described. No dependence, rebound or discontinuation syndrome has been reported for cod liver oil in any form, and abrupt cessation carries no recognised consequence.

  • Tapering: not applicable. The fat-soluble fractions clear slowly on their own — red-cell omega-3 over weeks, liver retinol over months — so the body tapers itself without any dose reduction schedule.

  • Cycling for efficacy: no efficacy argument supports cycling and no tolerance develops. A seasonal pattern is nonetheless coherent, since the vitamin D rationale disappears in summer sunlight at temperate latitudes.

  • Cycling to limit vitamin A accumulation: the stronger case for interruption. Some practitioners run the oil for the darker six months and stop for the rest, halving annual retinol exposure without losing the winter vitamin D contribution.

Sourcing and Quality

  • Third-party testing and disclosure: the decisive quality question here. Certificates should cover peroxide value and anisidine value (measures of early and later oxidation), total oxidation, vitamins A and D, heavy metals and polychlorinated biphenyls, with named laboratories and test dates.

  • Declared vitamin figures: the fermented product’s supplement facts panel lists no vitamin A or D amount, so the dose cannot be calculated. Competing extra-virgin and steam-extracted cod liver oils publish both figures per serving.

  • Species and fishery certification: the manufacturer now sources Marine Stewardship Council-certified wild Alaska cod (Gadus macrocephalus) from the Bering Sea, addressing the earlier claim that the oil came from Alaska pollock (Gadus chalcogrammus) rather than cod.

  • Formulation choice: the liquid gives more servings per dollar and allows the oil to be smelled, which is the only practical freshness check available outside a laboratory. Capsules conceal rancidity entirely and cost more per serving.

  • Brands and comparators: Green Pasture is the only substantial fermented producer. Rosita Extra-Virgin, Nordic Naturals Arctic and Carlson are the commonly cited unfermented comparators, all of which declare vitamin A and D content per serving.

  • Storage and freshness on arrival: the smallest bottle finishable in two months is the safer purchase, the manufacture date matters more than the best-before date, and a paint or varnish smell on opening marks a degraded bottle.

Practical Considerations

  • Time to effect: red-cell omega-3 rises over 8–12 weeks and 25-hydroxyvitamin D over 6–8 weeks, so biomarker change is the earliest visible signal. Joint symptom change in the trial evidence took 12 weeks or more.

  • Common pitfall — assuming the label: because no vitamin A or D figure is declared, users routinely add a separate vitamin D supplement or a multivitamin and lose track of total ready-made retinol. Summing sources first avoids this.

  • Common pitfall — treating taste as a safety test: the flavoured versions mask the smell that would otherwise reveal a degraded bottle, which makes the unflavoured version the more informative purchase where the oil doubles as its own freshness check.

  • Common pitfall — dosing by the traditional teaspoon: older writing recommends a teaspoon, while the current serving is 2 mL. Copying the historical figure roughly doubles retinol exposure over years of daily use.

  • Regulatory status: sold as a dietary supplement in the United States and the European Union, so it is not reviewed for efficacy before sale, and its manufacturer is responsible for its own label claims and testing.

  • Cost and payer incentives: the fermented liquid runs about $41 for 6 fl oz, several times commodity cod liver oil. Neither is reimbursed by insurers or national health systems, so no payer favours either, and no guideline or funding channel runs through them.

  • Accessibility: available direct from the manufacturer and through traditional-foods retailers, with unrestricted online sale in most markets. No prescription, no supply constraint, and no import restriction in the major jurisdictions.

Interaction with Foundational Habits

  • Sleep: indirect and weak. No sedative or stimulant action; the plausible route is the omega-3 fraction’s effect on melatonin precursor availability, reported inconsistently. Taking the oil at dinner rather than at bedtime avoids nocturnal reflux and eructation, which is the only reliable sleep-related consideration.

  • Nutrition: direct and potentiating. Absorption of all four fractions requires dietary fat and bile, so the oil belongs with a meal containing 10 g or more of fat. It stacks with liver, egg yolk and fortified foods on ready-made vitamin A, which must be counted in the daily total.

  • Exercise: indirect and mildly favourable. In a cohort of 1,002 recreational cyclists, cod liver oil users showed a blunted C-reactive protein response to a 91 km race (Hansen et al., 2021). Marine omega-3 does not blunt hypertrophy, and no timing relative to training sessions is supported by evidence.

  • Stress management: indirect and weak. The omega-3 fraction is studied for mood and cortisol reactivity with mixed results, and no cod liver oil trial has measured a stress endpoint. Nothing about the oil interferes with breathwork, meditation or heat exposure practice.

Monitoring Protocol & Defining Success

Because the product declares no vitamin A or D content, monitoring is not optional here as it might be for a labelled supplement — it is the only way to know the delivered dose. Baseline testing before the first serving establishes 25-hydroxyvitamin D, serum retinol with fasting retinyl esters, albumin-corrected calcium, an omega-3 index and a liver enzyme panel. Those five values separate someone with room to move from someone already replete, and anchor later change to a personal baseline rather than a population range.

Ongoing monitoring follows a simple cadence: vitamin D status, retinol and calcium at 12 weeks, long enough for the omega-3 index to have responded and for vitamin A accumulation to register; then every 6–12 months if values sit in range, with liver enzymes annually. Anyone on an anticoagulant adds a clotting check at 4 weeks and after any dose change.

Biomarker Optimal Functional Range Why Measure It? Context/Notes
25-hydroxyvitamin D 40–60 ng/mL (100–150 nmol/L) Shows whether the undeclared vitamin D fraction contributes anything Conventional laboratories report 30–100 ng/mL as normal; the functional target is narrower. No fasting needed. Best paired with calcium
Serum retinol 40–60 µg/dL (1.4–2.1 µmol/L) The vitamin A fraction is the main long-term hazard Tightly regulated and stays normal until liver stores are large, so a normal result does not exclude accumulation. Drawn fasting
Fasting retinyl esters Below 10% of total vitamin A The one test that detects vitamin A overload before symptoms Retinyl esters are the stored form of vitamin A. Requires a 12-hour fast and a laboratory that fractionates vitamin A; ordered when retinol is high or intake prolonged
Omega-3 index 8–12% of red-cell fatty acids Confirms the marine fraction is actually delivered and absorbed No conventional reference range exists; below 4% is the high-risk zone. Reflects roughly the previous 8–12 weeks, so rechecking sooner is uninformative
Albumin-corrected serum calcium 9.0–9.8 mg/dL High blood calcium is the commonest presenting sign of vitamin A excess Conventional range extends to 10.5 mg/dL. Correction for albumin is essential, since uncorrected calcium misses cases. Fasting preferred
Alanine aminotransferase (ALT) 10–26 U/L women, 10–30 U/L men Vitamin A is directly toxic to the liver at cumulative doses ALT is a liver enzyme released when liver cells are damaged. Conventional upper limits near 40–55 U/L are too permissive for early detection. Drawn with aspartate aminotransferase (AST) and gamma-glutamyl transferase
International normalised ratio (INR) 2.0–3.0 for most warfarin indications The omega-3 and vitamin K2 fractions pull the clotting time in opposite directions INR is a standardised clotting-time index. Relevant only on warfarin; for everyone else no target exists, and bruising and bleeding from small cuts are tracked against personal baseline instead

Qualitative markers worth tracking alongside the laboratory values:

  • Night vision and adaptation to bright light, the classic vitamin A status signs
  • Morning joint stiffness duration, the endpoint the rheumatoid arthritis evidence addresses
  • Skin and lip dryness, cracking at the mouth corners, and hair shedding, which appear early in vitamin A excess
  • Headache and visual blurring, the warning signs of raised pressure around the brain
  • Easy bruising or prolonged bleeding from small cuts
  • Digestive tolerance: eructation, nausea, loose stools
  • The smell of the oil itself, checked at each new bottle

Emerging Research

  • Cod liver oil as a topical wound matrix: NCT07161830 is randomising 180 adults with diabetic foot ulcers to a fish-peptide matrix infused with cod liver oil plus standard care, or standard care alone, with complete wound closure at 12 weeks as the primary endpoint. Recruiting since December 2025.

  • Omega-3 and neurodegeneration biomarkers: NCT07312435 at the University of Oslo is testing B-vitamins with omega-3 fatty acids in 96 participants against neurofilament light chain, a blood marker of nerve-cell damage. A null result would weaken the cognitive case for any marine oil.

  • Combined vitamin A and D dosing: NCT06508099 is a phase 2 trial giving vitamins A and D together to 220 transplant recipients. It is one of very few current trials reporting on the two vitamins delivered as a pair rather than separately.

  • Whether fermentation-derived antioxidants matter in the body: the resistance to heat-induced aldehyde formation shown by Percival et al., 2020 has never been tested against a human outcome. A feeding study measuring circulating oxidation products would substantiate or dissolve the central marketing claim.

  • Whether the retinol–fracture association is causal: the cohort signal in Wu et al., 2014 has never been tested in a randomised bone-density trial. Mendelian randomisation (using inherited gene variants as a natural experiment) on retinol-transport variants could strengthen or dismantle this safety objection.

  • Whether oxidised marine oil harms people: the rat pregnancy findings of Albert et al., 2016 conflict with the null human trial of Ottestad et al., 2012. A longer human trial using deliberately oxidised oil would settle the most consequential open question for unrefined liver oils.

Conclusion

Fermented cod liver oil is a traditionally prepared whole-food oil supplying marine fats, ready-made vitamin A, some vitamin D and a little vitamin K. Its distinguishing claim is that slow breakdown of the livers, rather than heat, preserves compounds that protect the fragile fats.

The evidence for that claim is laboratory chemistry, some of it published with the manufacturer as a named contributor, and the foundation that endorses the product has disclosed payments from that same manufacturer. The critical laboratory report that started the dispute was itself sold by its author, so financial interest runs in both directions and neither side’s testing has been independently repeated. No human study of any kind has tested the fermented product.

What can be said rests on ordinary cod liver oil: it allows people with inflammatory joint disease to use less painkiller, it tracks with lower inflammation markers in active adults, and it did not prevent respiratory infection in a very large trial. Against that sits the steady build-up of ready-made vitamin A, linked in large population studies to hip fracture, which is the clearest long-term hazard of daily use.

The gap that matters most is not between the two camps but between both of them and the evidence. For an adult choosing a daily oil to take for decades, the fermented version currently supplies an unlabelled amount of the ingredient that carries the greatest cumulative risk.

Top - Benefits - Risks - Protocol